期刊
JOURNAL OF CELLULAR PHYSIOLOGY
卷 214, 期 2, 页码 513-527出版社
WILEY
DOI: 10.1002/jcp.21236
关键词
-
资金
- NIAMS NIH HHS [R01 AR52425] Funding Source: Medline
- NIDDK NIH HHS [R01 DK50190] Funding Source: Medline
Transforming growth factor-P (TGF beta) controls expression of plasminogen activator inhibitor type 1 (PAI-1), which regulates degradation of extracellular matrix proteins in fibrotic diseases. The TGF beta receptor-specific Smad 3 has been implicated in the PAI-1 expression. The mechanism by which non-Smad signaling contributes to this process is not known. We studied the cross-talk between Smad 3 and PI 3 kinase/Akt signaling in TGF beta-induced PAI-1 expression in renal mesangial cells. Inhibition of PI 3 kinase and Akt kinase blocked TGF beta- and Smad 3-mediated expression of PAI-1. In contrast, constitutively active PI 3 kinase and Akt kinase increased PAI-1 expression, similar to TGF beta. Inhibition of PI 3 kinase and Akt kinase had no effect on TGF beta-induced Smad 3 phosphorylation and its translocation to the nucleus. Notably, inhibition of PI 3 kinase-dependent Akt kinase abrogated TGF beta-induced PAI-1 transcription, without affecting binding of Smad 3 to the PAI-1 Smad binding DNA element. However, PI 3 kinase inhibition and dominant negative Akt kinase antagonized the association of the transcriptional coactivator CBP with Smad 3 in response to TGF beta, resulting in inhibition of Smad 3 acetylation. Together our findings identify TGF beta-induced PI 3 kinase/Akt signaling as a critical regulator of Smad 3-CBP interaction and Smad 3 acetylation, which cause increased PAI-1 expression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据